Yoni Falkson

Yoni Falkson has held a variety of roles in the pharmaceutical industry since 2006. In 2006, they were a Consultant at IMS Health. From 2009 to 2012, they were a Consultant II at Bridgehead International, and then from 2012 to 2016, they were Director of Global Commercial New Product Planning, CV/Metabolic and Director of Pricing and Reimbursement, Primary Care Business Unit at Pfizer, Inc. In 2016, they became Co-Founder of SpringWorks Therapeutics, and in 2017, they were a Strategic Advisor at Perception Neuroscience, which was later acquired by Atai Life Sciences. From 2018 to 2019, they were Senior Director and then Director of New Products Marketing and Planning at Regeneron. Currently, Yoni is Chief Operating Officer and Board Member/Senior Advisor at Gilgamesh Pharmaceuticals.

Yoni Falkson completed their MBA at NYU Stern School of Business from 2011 to 2014. Prior to that, they obtained a degree in Economics and Psychology from Cornell University between 2002 and 2006.